Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

BACKGROUND: Non-small cell lung cancer (NSCLC) is the predominant cause of death in patients with COPD, and the severity of COPD in NSCLC patients is classified mainly as mild to moderate. Most advanced NSCLC patients with mild to moderate COPD are treated with chemotherapy; however, the feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Omote, Norihito, Hashimoto, Naozumi, Morise, Masahiro, Sakamoto, Koji, Miyazaki, Shinichi, Ando, Akira, Nakahara, Yoshio, Hasegawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729822/
https://www.ncbi.nlm.nih.gov/pubmed/29270008
http://dx.doi.org/10.2147/COPD.S149456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729822/
https://www.ncbi.nlm.nih.gov/pubmed/29270008
http://dx.doi.org/10.2147/COPD.S149456

Ejemplares similares